NEW DELHI: Private equity major ChrysCapital has acquired 12.5 per cent equity stake in Ahmedabad-based pharma company Intas Pharmaceuticals for around Rs 53 crore.

The stake was acquired from ICICI Ventures. The deal which was signed on Wednesday, marks ChrysCapitals foray in pharma space, sources said.

The acquisition will be done through Mozart, a Mauritius-based subsidiary of ChrysCapital III.

ChrysCapital senior MD Ashish Dhawan told TOI “We are delighted to invest in the pharma sector, for which we have the requisite experience and the expertise within the firm.”




By Anupama

Leave a Reply

Your email address will not be published. Required fields are marked *